Rachel Vaknin - Dec 21, 2022 Form 4 Insider Report for Microbot Medical Inc. (MBOT)

Role
Chief Financial Officer
Signature
/s/ Rachel Vaknin
Stock symbol
MBOT
Transactions as of
Dec 21, 2022
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 05:15 AM
Previous filing
Jul 20, 2022
Next filing
Aug 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBOT Stock Option (Right to Buy) Award $0 +13K $0.00 13K Dec 21, 2022 Common Stock, par value $0.01 per share 13K $3.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on June 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.